Menu
Not yet recruiting NCT06520501

Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients

No phase Interventional MeSH

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Herbal Medicine Sambiloto, Brisk Walking, Brisk Walking and Herbal Medicine Sambiloto.
Who it may be relevant to
Registry conditions: MeSH. Basic parameters: 19 years — 39 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Problem Formulation 1. Does herbal medicine sambiloto affect the blood glucose levels of obese sufferers? 2. Does brisk walking affect blood glucose levels in obese sufferers? 3. Does the combination of bitter herbal medicine and brisk walking have an effect on blood glucose levels in obese sufferers? 4. Is there a difference in the effectiveness between herbal bitter and brisk walking and the combination on blood glucose levels in obese sufferers? Research Objectives General Objectives : The general aim of this research is to determine the difference in effectiveness between the herbal medicine Sambiloto and brisk walking as well as the combination on the blood glucose levels of obese sufferers. Specific Objective : 1. Knowing the effect of herbal medicine Sambiloto on blood glucose in obese sufferers. 2. Knowing the effect of brisk walking on blood glucose in obese sufferers. 3. To determine the effect of the combination of herbal medicine Sambiloto and brisk walking on blood glucose levels in obese sufferers.

Detailed description

This type of research uses the Quasi Experimental method type Non-equivalent control group design, with a research design in the form of two group pre test and post test design, in this study there are two groups that will be measured pretest before intervention and post test after intervention and 1 control group without being given intervention. The intervention group is divided into two groups, namely the group given the herbal medicine sambiloto, and the group given the Brisk Walking Exercise treatment. Quasi-experimental research design with research design in the form of two group pre test and post test design.

Interventions

  • Dietary supplement Herbal Medicine Sambiloto
    Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
  • Behavioral Brisk Walking
    Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
  • Combination product Brisk Walking and Herbal Medicine Sambiloto
    Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute. Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days

Primary outcome measures

  • Blood Glucose Differences [Time frame: 7 consecutive day]

Eligibility criteria

Inclusion criteria

  • Willing to be a respondent with informed consent
  • Obesity sufferers in the Jekan Raya District area
  • Have a BMI ≥ 25 kg/m2 (Obesity I)
  • Adult age (19-39 years)

Exclusion criteria

  • Not being present or out of town during the research
  • Unable to continue research due to serious illness or death
  • Withdraw while participating in the research
  • Have a history of drug allergies
  • Experiencing decreased consciousness
  • Experiencing an extremity injury
  • Have a history of cardiovascular disease, kidney disease or stomach ulcers
  • Have a history of bloody stools
  • Are pregnant or breastfeeding

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06520501 · 2504031946

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗